Non-Coding RNAs in Lung Cancer: Contribution of Bioinformatics Analysis to the Development of Non-Invasive Diagnostic

Meik Kunz1, Beat Wolf2,3, Harald Schulze4

  • 1Functional Genomics and Systems Biology Group, Department of Bioinformatics, Biocenter, University of Wuerzburg, 97074 Wuerzburg, Germany. meik.kunz@uni-wuerzburg.de.

Genes
|December 31, 2016
PubMed

Insights

Non-coding RNAs, including microRNAs and long non-coding RNAs, show promise as early lung cancer biomarkers. Bioinformatics tools aid in developing non-invasive diagnostic methods for lung cancer.

Area of Science:

  • Biochemistry and Molecular Biology
  • Genomics
  • Oncology

Background:

  • Lung cancer remains a leading cause of cancer mortality, often due to late diagnosis and limited treatment options.
  • Non-coding RNAs (ncRNAs) are crucial gene expression regulators, not translated into proteins.
  • MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are implicated in lung cancer development and progression.

Approach:

  • This review highlights the potential of ncRNAs as non-invasive biomarkers for early lung cancer detection.
  • It explores the application of bioinformatics algorithms and software tools for understanding ncRNA function.
  • The focus is on developing novel, non-invasive diagnostic tools for lung cancer.

Key Points:

  • ncRNAs, specifically miRNAs and lncRNAs, are emerging as promising biomarkers for early lung cancer diagnosis.
  • Bioinformatics approaches are essential for comprehensive analysis and functional characterization of these ncRNAs.
  • The integration of ncRNA research and bioinformatics can lead to improved non-invasive diagnostic strategies.

Conclusions:

  • ncRNAs represent a significant advancement in the search for early lung cancer biomarkers.
  • Bioinformatics plays a critical role in unlocking the diagnostic potential of ncRNAs.
  • Further research in this area could revolutionize lung cancer diagnostics and patient outcomes.